Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Merck $8 billion notes offering
We advised the underwriters on the notes offering
Illumina $500 million notes offering
We advised the underwriters on the offering
Olema Pharmaceuticals $218.5 million follow-on offering
We advised the underwriters on the offering
Bristol Myers Squibb $7 billion cash tender offer
We advised the dealer managers on the tender offer
Inventiva $172.5 million follow-on offering
We advised the underwriters on the offering
Ionis Pharmaceuticals $770 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
GRAIL $300 million at-the-market offering
We advised the sales agents on the offering
Novartis $6 billion notes offering
We advised Novartis on the investment-grade debt offering
Novanta $632.5 million tangible equity units offering
We advised the representatives of the several underwriters on the offering